BLASUBCUTANEOUSINJECTABLE
Approved
Mar 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
FOLLISTIM AQ (follitropin) by Merck & Co. is women: follicle-stimulating hormone (fsh), the active component in follistim aq cartridge, is required for normal follicular growth, maturation, and gonadal steroid production. First approved in 2004.
Drug data last refreshed 13h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FOLLISTIM AQ (follitropin) is a recombinant follicle-stimulating hormone (FSH) gonadotropin administered subcutaneously for fertility treatment in women and men. In women, it stimulates ovarian follicular growth and maturation for assisted reproductive technologies; in men with hypogonadotropic hypogonadism, it stimulates spermatogenesis when co-administered with hCG. The drug mimics the natural pituitary FSH hormone required for normal reproductive function.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential team restructuring and shift toward lifecycle management and cost-containment strategies.
Mechanism of Action
Women: Follicle-stimulating hormone (FSH), the active component in FOLLISTIM AQ Cartridge, is required for normal follicular growth, maturation, and gonadal steroid production. In women, the level of FSH is critical for the onset and duration of follicular development, and consequently for the…
Pharmacologic Class:
Gonadotropin
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Started Feb 2026
266 enrolled
Infertility
Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)
Started Dec 2025
80 enrolled
InfertilityInsemination
A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants
Started Jul 2025
55 enrolled
Hypogonadism
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.
Started Jul 2024
106 enrolled
Infertility
An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation
Started Jun 2024
310 enrolled
Fertility
Worked on FOLLISTIM AQ at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.